MAIA Stock Analysis: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.39
0.01 (0.72%)
▲
5d:
+5.3%
30d:
+8.59%
90d:
-3.47%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MAIA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MAIA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.10
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.39, which is considered slightly high relative to its 30-day fair value range of $1.27 to $1.39. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.2) compared to its historical average (0.7). At these levels, the market is pricing in 21.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.26, while resistance sits at $1.56.
Market Sentiment: MAIA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.13 (+779.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.26, while resistance sits at $1.56.
Market Sentiment: MAIA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.13 (+779.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.27 -
$1.39
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 779.3% below Wall St target ($12.13)
- NEUTRAL: Trading at premium valuation - market expects 21.3% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$1.27 -
$1.39
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.26
Resistance Level
$1.56
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.23
Wall Street Target
$12.14
(+779.3%)
Valuation Premium vs History
+21.3% premium
PE vs Historical
1.2 vs 0.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+21.3%
(market-implied from PE analysis)
1-Year Target
$1.67
(+21%)
2-Year Target
$2.03
(+47%)
3-Year Target
$2.46
(+79%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$1.40
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 24, 2026 4:43 PM ET
Data refreshes hourly during market hours. Next update: 5:43 PM
Data refreshes hourly during market hours. Next update: 5:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
